Study of JNJ-78934804 (guselkumab and golimumab) versus guselkumab in adults with moderately to severely active Crohn’s disease
- Substances:Golimumab
Norway- Participants:18–64 years · 65+ years
- Substances:Golimumab
- Sponsor:Janssen Cilag International
Rare diseases
Investigational molecules
Locations
Back to Norway142 clinical trials in Tromsø, Norway across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in NorwayKliniske-Studier.no(opens in a new tab)
NorwayRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
NorwayBI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases
NorwayA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
NorwayA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
NorwayA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
NorwayStudy on ZED1227 for Improving Symptoms in Celiac Disease Patients on a Gluten-Free Diet
NorwayStudy of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer
NorwayEfficacy and Safety of JNJ-78934804 (guselkumab and golimumab) in Adults with Moderately to Severely Active Ulcerative Colitis
NorwayRinatabart Sesutecan plus bevacizumab vs standard care as maintenance for recurrent platinum‑sensitive ovarian cancer after second‑line chemotherapy
NorwayNipocalimab in Adults with Moderate to Severe Systemic Lupus Erythematosus
NorwayN1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD
NorwayThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on innovative cancer treatments, including research on rare cancers, hepatoblastoma, and testicular cancer. Studies explore personalized treatment approaches and drug efficacy evaluation.
Novel therapeutic strategies and targeted treatments are being investigated to improve patient outcomes.
Research focusing on Alzheimer's disease treatment and acute ischemic stroke management. Studies evaluate new drug comparisons and therapeutic interventions.
Emphasis on developing effective therapeutic approaches for neurodegenerative conditions.
Comprehensive studies addressing various childhood conditions, including acute wheezing, leukemia, and respiratory infections.
Focus on improving treatment outcomes in young patients through innovative therapeutic approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.